P362 Six-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients

MLA

C Cassieri, et al. “P362 Six-Year Efficacy and Safety of Azathioprine Treatment in the Maintenance of Steroid-Free Remission in Inflammatory Bowel Disease Patients.” Journal of Crohn’s and Colitis, vol. 12, Jan. 2018, p. S287. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9dd0fe09355769362845bec92a5bc60b&authtype=sso&custid=ns315887.

APA

C Cassieri, R Pica, E V Avallone, G Brandimarte, M Zippi, P Crispino, D De Nitto, P G Lecca, P Vernia, P Paoluzi, & E S Corazziari. (2018). P362 Six-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients. Journal of Crohn’s and Colitis, 12, S287.

Chicago

C Cassieri, R Pica, E V Avallone, G Brandimarte, M Zippi, P Crispino, D De Nitto, et al. 2018. “P362 Six-Year Efficacy and Safety of Azathioprine Treatment in the Maintenance of Steroid-Free Remission in Inflammatory Bowel Disease Patients.” Journal of Crohn’s and Colitis 12 (January): S287. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9dd0fe09355769362845bec92a5bc60b&authtype=sso&custid=ns315887.